Roy Galvin serves as the Executive Vice President and Chief Commercial Officer at Haemonetics Corporation, a global healthcare company focused on blood and plasma supply chain solutions. In his role, Galvin is responsible for overseeing the company's global commercial operations, driving strategic initiatives to enhance market presence, and ensuring the delivery of innovative solutions to customers worldwide. His leadership has been instrumental in advancing Haemonetics' mission to improve patient outcomes and optimize healthcare systems. Before joining Haemonetics, Galvin held various senior leadership positions in the healthcare and medical device industries. He has a proven track record of successfully leading commercial teams and implementing growth strategies that have resulted in increased market share and revenue growth. Galvin's extensive experience in the sector, combined with his strategic vision, has enabled him to make significant contributions to Haemonetics' success. Under his guidance, the company has expanded its portfolio of products and services, strengthened its position in key markets, and fostered strong relationships with healthcare providers and partners. Galvin's achievements at Haemonetics include the successful launch of several innovative products and the expansion of the company's global footprint. He has been a key driver in the development and execution of Haemonetics' commercial strategy, focusing on customer-centric solutions and operational excellence. His dedication to advancing the field of blood and plasma management has earned him recognition within the industry and among his peers. As Haemonetics continues to grow and innovate, Galvin's leadership will remain pivotal in shaping the company's future and delivering value to stakeholders.